Our Mission and Values

Our mission is to provide uncommon therapies so patients achieve “No Evidence of Disease.” Uncommon therapies are those that lack customary toxicity and side effects and allow patients on our treatments to live life fully and are suitable for patients globally, including those in areas of the world plagued by health disparities.

Our mission is driven by our values:

  • The needs and desires of patients and their families;
  • Integrity in everything that we do;
  • Scientifically grounded optimal solutions driven by continuous attention to new research findings;
  • Belief in the body’s innate ability to re-learn health;
  • Commitment to challenging what “cannot be done.”

Leadership and Management

  • Geoffrey Ling, MD, PhD, Col. (Ret.)
    Geoffrey Ling, MD, PhD, Col. (Ret.)
    Office of the CEO, Scientific Advisory Board of Advisors, Board of Directors
  • Rebecca Lambert
    Rebecca Lambert
    Founder and Executive Chair, Office of the CEO
  • Brian Leyland Jones, BSc, MB BS, PhD, FRACP, FRCPC
    Brian Leyland Jones, BSc, MB BS, PhD, FRACP, FRCPC
    Scientific Advisory Board Chairman, Office of the CEO
  • Craig Eastwood, CPA
    Craig Eastwood, CPA
    Chief Financial Officer
  • Peter D’Errico
    Peter D’Errico
    Chief Operating Officer
  • Michael Mansour, MD, PhD
    Michael Mansour, MD, PhD
    Chief Medical Advisor - Infectious Disease
  • Lou Vaickus, MD, FACP
    Lou Vaickus, MD, FACP
    Chief Medical Advisor - Oncology
  • Sue Stewart, JD
    Sue Stewart, JD
    Senior Regulatory Adviser
  • Beth Silverstein, MS, RAC
    Beth Silverstein, MS, RAC
    Regulatory Advisor
  • Gary Elliot, RPh, PharmD, PhD
    Gary Elliot, RPh, PharmD, PhD
    CMC and Product Development
  • Brenda Jarrell, PhD, JD
    Brenda Jarrell, PhD, JD
    IP Counsel
  • Elinor Mullins
    Elinor Mullins
    Business Operations Manager

Board of Directors

  • Geoffrey Ling, MD, PhD, Col. (Ret.)
    Geoffrey Ling, MD, PhD, Col. (Ret.)
    Office of the CEO, Scientific Advisory Board of Advisors, Board of Directors
  • Rebecca Lambert
    Rebecca Lambert
    Founder and Executive Chair, Office of the CEO
  • Randall Barko
    Randall Barko
    Board of Directors
  • Mary Davis
    Mary Davis
    Board of Directors
  • Josh Kopelman – First Round Capital
    Josh Kopelman – First Round Capital
    Board Observer

Lead Investors

  • First Round Capital
    First Round Capital
    Series A Lead Investor
  • Benjamin H. Griswold, IV
    Benjamin H. Griswold, IV
    Series B Lead Investor

Scientific Advisory Board

  • Geoffrey Ling, MD, PhD, Col. (Ret.)
    Geoffrey Ling, MD, PhD, Col. (Ret.)
    Office of the CEO, Scientific Advisory Board of Advisors, Board of Directors
  • Brian Leyland Jones, BSc, MB BS, PhD, FRACP, FRCPC
    Brian Leyland Jones, BSc, MB BS, PhD, FRACP, FRCPC
    Scientific Advisory Board Chairman, Office of the CEO
  • Gail M. Fennell, MD
    Gail M. Fennell, MD
    Scientific Advisor
  • Edward Garmey, MD
    Edward Garmey, MD
    Scientific Advisor
  • Dudley R. Herschbach, PhD
    Dudley R. Herschbach, PhD
    Scientific Advisor
  • Judith E. Karp, MD
    Judith E. Karp, MD
    Scientific Advisor
  • Robert S. Kerbel, PhD
    Robert S. Kerbel, PhD
    Scientific Advisor
  • Razelle Kurzrock, MD
    Razelle Kurzrock, MD
    Scientific Advisor
  • Marsha A. Moses, PhD
    Marsha A. Moses, PhD
    Scientific Advisor

Strategic Advisory Council

  • Fiona Calnan FCCA, FRSA
    Fiona Calnan FCCA, FRSA
    Strategic Advisor
  • Christine Davis
    Christine Davis
    Strategic Advisor
  • Stephanie Fierman
    Stephanie Fierman
    Strategic Advisor
  • Jean Hamilton
    Jean Hamilton
    Strategic Advisor
  • Gale Pollock, CRNA, FACHE, FAAN, Maj. Gen. (Ret)
    Gale Pollock, CRNA, FACHE, FAAN, Maj. Gen. (Ret)
    Strategic Advisor
  • Randy Slack
    Randy Slack
    Strategic Advisor
  • John Warden III, Col. (Ret)
    John Warden III, Col. (Ret)
    Strategic Advisor
  • Diane M. Whitty
    Diane M. Whitty
    Strategic Advisor
  • Analisa L. Balares
    Analisa L. Balares
    Global Advisor
  • Jeffrey Yang
    Jeffrey Yang
    Strategic Advisor

Advisors

  • Joy Horng
    Joy Horng
    Scientific Research Task Force
  • Brett Macias
    Brett Macias
    Creative Director and Program Manager
  • Amaal Mahamed
    Amaal Mahamed
    Scientific Research Task Force
  • Susan Paulson, PhD
    Susan Paulson, PhD
    Clinical Pharmacology Advisor
  • Tina M. Tockarshewsky
    Tina M. Tockarshewsky
    Community Engagement Advisor
  • Paul Woitach 
    Paul Woitach 
    CMC Advisor